AC Immune (ACIU) Share-based Compensation (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 11.29% |
| Sep 30, 2025 | -24.94% |
| Jun 30, 2025 | -21.86% |
| Mar 31, 2025 | 56.99% |
| Dec 31, 2024 | -21.99% |
| Sep 30, 2024 | -8.27% |
| Jun 30, 2024 | -28.46% |
| Mar 31, 2024 | 139.97% |
| Dec 31, 2023 | -8.46% |
| Sep 30, 2023 | -28.19% |
| Jun 30, 2023 | -14.11% |
| Mar 31, 2023 | 72.46% |
| Dec 31, 2022 | 60.58% |
| Sep 30, 2022 | -38.30% |
| Jun 30, 2022 | -13.03% |
| Mar 31, 2022 | -5.51% |
| Dec 31, 2021 | -24.98% |
| Sep 30, 2021 | 64.57% |
| Jun 30, 2021 | -3.16% |
| Mar 31, 2021 | -15.07% |
| Dec 31, 2020 | -16.61% |
| Sep 30, 2020 | 29.61% |
| Jun 30, 2020 | 17.23% |
| Mar 31, 2020 | 8.03% |
| Dec 31, 2019 | -8.92% |
| Sep 30, 2019 | 60.00% |
| Jun 30, 2019 | -4.58% |
| Mar 31, 2019 | -6.03% |
| Dec 31, 2018 | 5.31% |
| Sep 30, 2018 | -18.08% |
| Jun 30, 2018 | 13.96% |
| Mar 31, 2018 | 100.08% |
| Dec 31, 2017 | -197.37% |
| Sep 30, 2017 | 421,634.51% |
| Jun 30, 2017 | 103.82% |
| Mar 31, 2017 | -89.70% |
| Dec 31, 2016 | 528.88% |
| Sep 30, 2016 | 49.20% |
| Jun 30, 2016 | 169.36% |
| Mar 31, 2016 | -33.57% |